Oversight and Investigations Hearing: Oversight Of 340B Drug Pricing Program

Oversight and Investigations Hearing: Oversight Of 340B Drug Pricing Program

Congresswoman Lesko Remarks at Energy and Commerce Committee's Oversight and Investigations HearingПодробнее

Congresswoman Lesko Remarks at Energy and Commerce Committee's Oversight and Investigations Hearing

20240604 Hearing Oversight Of 340B Drug Pricing Program Full VideoПодробнее

20240604 Hearing Oversight Of 340B Drug Pricing Program Full Video

Hearing on Oversight of 340B Drug Pricing ProgramПодробнее

Hearing on Oversight of 340B Drug Pricing Program

Oversight and Investigations Hearing on 340B Drug Pricing Program October 11, 2017Подробнее

Oversight and Investigations Hearing on 340B Drug Pricing Program October 11, 2017

Health Hearing of Opportunities to Improve the 340B Drug Pricing Program (07/11/2018)Подробнее

Health Hearing of Opportunities to Improve the 340B Drug Pricing Program (07/11/2018)

Rep. Carter Q&A E&C Hearing "Examining HRSAs Oversight of the 340B Drug Pricing Program"Подробнее

Rep. Carter Q&A E&C Hearing 'Examining HRSAs Oversight of the 340B Drug Pricing Program'

Examining HRSA’s Oversight of the 340B Drug Pricing ProgramПодробнее

Examining HRSA’s Oversight of the 340B Drug Pricing Program

Oversight and Investigations Hearing on HRSA’s Oversight of 340B (07/18/2017)Подробнее

Oversight and Investigations Hearing on HRSA’s Oversight of 340B (07/18/2017)

Oversight and Investigations Hearing on 340B Drug Pricing Program (10/11/2017)Подробнее

Oversight and Investigations Hearing on 340B Drug Pricing Program (10/11/2017)